ArticleCurrent oncology (Toronto, Ont.)2026
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression.
Xiaojuan Yang, Zhiwei Zhang, Shuangjuan Lv, Buzhe Zhang, Xue Tao, Chang Liu, Qing Zhu
Abstract read
In one paragraphArticle in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Xiaojuan YangDepartment of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0009-0006-9430-6482 Zhiwei ZhangDepartment of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.
Shuangjuan LvLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Buzhe ZhangLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Xue TaoLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Chang LiuDepartment of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.
Qing ZhuDepartment of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610041, China.
Funding
Peak Discipline Operation Fund of West China Hospital GFYX25004Postdoctoral Research Funds of West China Hospital, Sichuan University 2025HXBH050 and 2025HXBH103Science and Technology Support Programs of Sichuan Province 2025ZNSFSC1901 and 2026NSFSC1950State-Owned Assets Supervision and Administration Commission Program C GZC20251423
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
DNA-Binding ProteinsE2F1 Transcription FactorPancreatic NeoplasmsAnimalsApoptosisCell CycleCell Line, TumorCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticHumansMiceDNA-Binding ProteinsE2F1 protein, humanE2F1 Transcription Factorcell cycleE2F1pancreatic cancertumor proliferationWDHD1
Identifiers
PMID42041705
PMCPMC13115010
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390